Just as working from home has become the “new normal,” clinical trials have had to adapt to pandemic restrictions that prevented the collection of data in the standard way.

TORONTO (PRWEB)
May 04, 2021

Just as working from home has become the “new normal,” clinical trials have had to adapt to pandemic restrictions that prevented the collection of data in the standard way. From local safety orders to the fear participants have when leaving their home, trial protocols were strained. Some trials paused or were canceled, while others found innovative ways to continue their studies in this “new normal.”

Register for this webinar to hear an expert from Egnyte discuss what clinical trials will

look like once safety restrictions have been lifted. Including which trends from the COVID-19 pandemic will be carried forward and who the leaders will be when trials resume.

Join James Allgood, Product Marketing, Life Sciences, Egnyte, for the live webinar on Monday, May 24, 2021 at 1pm EDT (10am PDT).

For more information, or to register for this event, visit Post-COVID Clinical Trials: 3 Predictions for the Future.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: